US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
LTR Pharma Ltd (LTP) 銘柄情報

LTR Pharma Ltd (LTP)

0.50

0.075

(17.65%)

終了 6月11日 3:00PM

LTR Pharma Ltd (LTP) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.50

( 17.65% )

買値

0.50

売値

0.51

出来高

2,211,908

0.445 日の範囲 0.535

0.27 52 週間の範囲 0.81

時価総額

前日終値

0.425

始値

0.475

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 305,749

発行済株式数

181,777,585

配当利回り

PER

-9.42

1 株当たり利益 (EPS)

-0.05

歳入

1.13M

純利益

-8.95M

LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for t... LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.ltrpharma.com

本社

Brisbane, Australia

設立

2026

LTR Pharma Ltd is listed in the sector of the オーストラリア証券取引所 with ticker LTP. The last closing price for LTR Pharma was AUD0.43. Over the last year, LTR Pharma shares have traded in a share price range of AUD 0.27 to AUD 0.81.

LTR Pharma currently has 181,777,585 shares in issue. The market capitalisation of LTR Pharma is AUD90.89 million. LTR Pharma has a price to earnings ratio (PE ratio) of -9.42.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.13	35.1351351351	0.37	0.54	0.365	747985	0.46401462	DE
4	0.09	21.9512195122	0.41	0.54	0.35	355459	0.42139051	DE
12	0.065	14.9425287356	0.435	0.63	0.35	348243	0.43427314	DE
26	0.015	3.09278350515	0.485	0.75	0.35	313063	0.49199281	DE
52	0.195	63.9344262295	0.305	0.81	0.27	484900	0.49417547	DE
156	0.15	42.8571428571	0.35	2.15	0.235	599063	0.75388185	DE
260	0.15	42.8571428571	0.35	2.15	0.235	599063	0.75388185	DE

LTP - Frequently Asked Questions (FAQ)

What is the current LTR Pharma Ltd share price?

The current share price of LTR Pharma Ltd is AUD 0.50

How many LTR Pharma Ltd shares are in issue?

LTR Pharma Ltd has 181,777,585 shares in issue

What is the market cap of LTR Pharma Ltd?

The market capitalisation of LTR Pharma Ltd is AUD 90.89M

What is the 1 year trading range for LTR Pharma Ltd share price?

LTR Pharma Ltd has traded in the range of AUD 0.27 to AUD 0.81 during the past year

What is the PE ratio of LTR Pharma Ltd?

The price to earnings ratio of LTR Pharma Ltd is -9.42

What is the cash to sales ratio of LTR Pharma Ltd?

The cash to sales ratio of LTR Pharma Ltd is 74.71

What is the registered address of LTR Pharma Ltd?

The registered address for LTR Pharma Ltd is 29/97 Creek Street, Brisbane, Queensland, 4000

What is the LTR Pharma Ltd website address?

The website address for LTR Pharma Ltd is www.ltrpharma.com

gwih

Oops. I was wrong… you didn’t get the message. Too bad, but at least I gave you the benefit of doubt. I know enough now (“based on 40+ years extensive experience in observation of social behaviour” 🤓). Whatever I invest in, it will not be in discussion with you anymore.

rayovac812

rayovac812 10分前

A bit of a peak into how easily marketable this is going to be. Best piece of marketing I've seen as well. That kind of language wasn't in the article that kicked off the recent run. It is new found confidence. Now show us the reason for the linguistic upgrade. Something is going on.

US Market News

US Market News 23分前

AeroVironment, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AVAVJune 11, 2026 2:20 AM
PR Newswire (US) class="legendSpanClass"LOS ANGELES, class="legendSpanClass"June 11, 2026 /PRNewswire/

DeadCellShadix

DeadCellShadix 24分前

Well done brother!

ducci1

ducci1 28分前

satter

satter 29分前

Bingo. I knew if you came back it would be with that document. Good so now I get to explain textbook lesson in corporate litigation strategy by calling Natario that.

Under corporate law, a company can argue it isn’t liable if an outside third party uses its identity to commit a fraud.

ducci1

ducci1 29分前

Pivot Calcs: SPX Pivot 7309---R1 7353---S1 7222----SPY Pivot 729---R1 733---S1 720----ES Pivot 7317---R1 7402---S1 7228----VIX Pivot 21.64---R1 23.23---S1 20.63---15 min Bull//Bear R/line 19.14!-----!!LOL!! --- ( !!LOL!!--Historical Internet Usage Was !! Lots of Luck!! --Readers Choice

BeamMeUpScotty

BeamMeUpScotty 32分前

He was a threatening litigious bully who bit off more than he could chew with this ticker and employed what I can only describe as the worst corporate advisers on the planet !

PavilionInvestor

PavilionInvestor 33分前

It might be a difficult concept to understand for some

Quick Sand

Quick Sand 37分前

Pffffft Rubbish !

Breaking NDA’s can get you in a bit hot water.

🤡🤣🤣🤣🤣🤣🤣🤣

US Market News

US Market News 38分前

ACI Worldwide Powers Next-Generation PSP Expansion in Africa with Kwik Payments Go-LiveJune 11, 2026 2:00 AM
Business Wire Kwik Payments utilizes ACI’s Payments Orchestration Platform to help merchants reduce checkout friction and drive conversion uplifts of mo

US Market News

US Market News 38分前

Guardian Metal Resources PLC Announces Board UpdateJune 11, 2026 2:00 AM
ACCESS NewswireLONDON, UK / ACCESS Newswire / June 11, 2026 / Further to its announcement of board changes on 21

US Market News

US Market News 38分前

Vertex Presents New Data on CASGEVY®, Including First European Presentation of Data in Children Ages 5–11, at the European Hematology Association Congress and Announces Additional Global Regulatory SubmissionsJune 11, 2026 2:01 AM
Business Wire - Data from pivo

US Market News

US Market News 38分前

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven disease with no FDA-approved therapiesJune 11, 2026 2:03 AM
PR Newswire (US)

US Market News

US Market News 38分前

Sportradar Group AG Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SRADJune 11, 2026 2:12 AM
PR Newswire (US) class="legendSpanClass"LOS ANGELES, class="legendSpanClass"June 11, 2026 /PRNewswire/

BeamMeUpScotty

BeamMeUpScotty 40分前

So still no fillings or financials? Or maybe all the money is in Panama? Lol Or a Cayman Islands account! lol

rx7171

rx7171 41分前

Uplist to Nasdaq was promised for May however replacing CFO has delayed it but should be within the next two months.
That should be a catalyst.

StockItOut

StockItOut 42分前

Dec.’s a good point, yet a ways off.
Thinking the .0002s don’t really have incentive to sell at .0001 as MDCE retail can’t go lower, and any 1s buyers will want out at least at 2s, so why would 2s sell to meet the bid at 0.0001 when they are just as likely to sell even, at minimum. The 1s m

DRISCHAR

DRISCHAR 49分前

I have 101 million shares. And just grinning ear to ear

Wolf-man jack

Wolf-man jack 52分前

WQLF SAYS: CV SCIENCES Plus CBD Products are Eligible according to the CMS Guidelines. Have Mercy WQLF ahoooooo

. TANK SAID: However, seniors cannot simply buy them and get Medicare reimbursement. A participating CMS model provider would have to choose eligible products, include the

US Market News

US Market News 53分前

Commvault Systems, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CVLTJune 11, 2026 1:51 AM
PR Newswire (US) class="legendSpanClass"LOS ANGELES, class="legendSpanClass"June 11, 2026 /PRNewswi

Mistervane

Mistervane 57分前

I emailed Jay Wright, the most recent person to have any business transaction with George, and this was his reply:
My understanding is that Mr. Sharp did indeed pass away. I know that he had some health issues over the past year but do not know of any details.

Thank you for you

Mistervane

Mistervane 58分前

I emailed Jay Wright, the most recent person to have any business transaction with George, and this was his reply:
My understanding is that Mr. Sharp did indeed pass away. I know that he had some health issues over the past year but do not know of any details.

Thank you for y

TheRealShimSlady

TheRealShimSlady 60分前

Nvidia apple

https://www.linkedin.com/safety/go/?url=https%3A%2F%2Fbit%2Ely%2F3PQdeSL&urlhash=B7wI&mt=OVZkqKkDVmHFOrxI4xn8E2LjpunZRY-WovETZXXg_RM98TKS9MTNtFuQ0BH24lLyIwnKhQRi34JSjKVcTv1ULt8YOhubX7It2SSBfq5aqe98e5QOSi4hg5QT0n4&isSdui=true

JohnnyRotton

JohnnyRotton 1時間前

Hmmm, 26.5 billion is pretty steep OS. Only three fixes, buyback or reverse split. Or spin off brand. I'm sure they have considered all three.

PHLX Canadian Dollar

Global SPAC Partners

Franklin US Core Bond ETF

Ci Global Climate Leader...

Exemplar Growth and Inco...

Phillips Edison

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。